Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives

Before the introduction of tyrosine kinase inhibitors (TKIs) for a particular subgroup of patients, despite platinum-based combination chemotherapy, the majority of patients affected by non-small-cell lung cancer (NSCLC) did not live longer than one year. With deeper understanding of tumor molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrara, Miriam Grazia, Di Noia, Vincenzo, D’Argento, Ettore, Vita, Emanuele, Damiano, Paola, Cannella, Antonella, Ribelli, Marta, Pilotto, Sara, Milella, Michele, Tortora, Giampaolo, Bria, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281569/
https://www.ncbi.nlm.nih.gov/pubmed/32397295
http://dx.doi.org/10.3390/cancers12051196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281569/
https://www.ncbi.nlm.nih.gov/pubmed/32397295
http://dx.doi.org/10.3390/cancers12051196

Ejemplares similares